Live Zoster Vaccination and Cardiovascular Outcomes: A Nationwide, South Korean Study | Impact of Nirsevimab on RSV and Non-RSV Severe Respiratory Infections in Hospitalized Infants | Early Effectiveness of the BNT162b2 KP.2 Vaccine against COVID-19 in the U.S. Veterans Affairs Healthcare System
Tocilizumab and IVIG Experience During the Service Follow-up in Patients with Severe COVID-19 Pneumonia | Risk of New-Onset Type 2 Diabetes among Vaccinated Adults after Omicron or Delta Variant SARS-CoV-2 Infection
From May 1 to July 31, 2025, all donations made to PWB will be matched and donated to FIMRC, and no matter how many donations are received, PWB pledges a minimum donation of $10,000 and a total gift of up to $20,000.
Fundraiser Kickoff for the Foundation for International Medical Relief of Children Read More »
Efficacy, Safety, and Immunogenicity of the AS01E-adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over Three Respiratory Syncytial Virus Seasons (AReSVi-006): A Multicentre, Randomized, Observer-blinded, Placebo-Controlled, Phase 3 Trial | Long-Term Stroke and Mortality Risk Reduction Associated With Acute-Phase Paxlovid Use in Mild-to-Moderate COVID-19
Respiratory Syncytial Virus and Incidence of Cardiovascular Events: A Nationwide Self-Controlled Case Series Analysis | Comorbidities Associated with Different Degrees of Severity in Children and Young People Hospitalized with Acute COVID-19 | SHIELD-Utah Study Shows Novavax’s COVID-19 Vaccine Induces Lower Reactogenicity Symptoms Compared to mRNA
Human Source SARS-CoV-2 Aerosol Transmission to Remote Sentinel Hamsters | Nirmatrelvir–ritonavir versus Placebo–ritonavir in Individuals with Long COVID in the USA (PAX LC): A Double-blind, Randomized, Placebo-controlled, Phase 2, Decentralized Trial | Quantitative Brain Volume Differences Between COVID-19 Patients and Non-COVID-19 Volunteers: A Systematic Review
For nearly a decade, Parasites Without Borders has worked with Floating Doctors, a global nonprofit dedicated
to reducing the burden of disease in the developing world and promoting improvements in healthcare delivery
worldwide.
Global Health Nonprofit Puts Boots to the Ground With Floating Doctors Read More »
Early Impact of RSV Vaccination in Older Adults in England | Evaluating the Effectiveness of 2024-2025 Seasonal mRNA-1273 Vaccination Against COVID-19-Associated Hospitalizations and Medically Attended COVID-19 among adults aged ≥18 years in the United States | Metformin Alleviates Inflammatory Response and Severity Rate of COVID-19 Infection in Elderly Individuals
Lower Levels of Household Transmission of SARS-CoV-2 Omicron Variant of Concern vs Wild Type: An Interplay Between Transmissibility and Immune Status | The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients with Kidney Disease: A Propensity Score–Matched Study | Effect of Pulmonary Rehabilitation for Patients with Long COVID-19: A Systematic Review and Meta-analysis of Randomized Controlled Trials
The Burden of All-Cause Mortality Following Influenza-Associated Hospitalizations: Influenza Hospitalization Surveillance Network, 2010–2019 | COVID-19 Antiviral Medication Use Among Pregnant and Recently Pregnant U.S. Outpatients | TGFβ Links EBV to Multisystem Inflammatory Syndrome in Children
A comprehensive educational resource on all aspects of parasitic diseases and their impact on humanity around the globe.
Help bring the latest medical and basic biological information pertaining to diseases caused by eukaryotic parasites to every practicing physician and medical student within the United States.
English 
Spanish